Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

NCT06451172 is registered in ClinicalTrials.gov with Eye & ENT Hospital of Fudan University as lead sponsor.

NCT NCT06451172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06451172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
Lead sponsor
Eye & ENT Hospital of Fudan University
Phase
Phase 1
Overall status
Recruiting
Start date
October 11, 2023
Completion date
October 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibacterial therapy, antibiotic-resistant bacteria, antisense peptide nucleic acid, bacterial keratitis, blindness, corneal diseases, eye diseases, infections, bacterial, sensation disorders, vision disorders